Skip to main content
Premium Trial:

Request an Annual Quote

Seven Bridges Invests in Sweden's Spatial Transcriptomics, Inks Strategic Partnership

NEW YORK (GenomeWeb) – Seven Bridges has announced an investment in Spatial Transcriptomics, a Stockholm-based firm developing gene expression visualization technology for tissue sample sections.

Seven Bridges said in a statement that the investment is the first step in building a strategic partnership and would help Spatial Transcriptomics reach more scientists by making its technology available on the Seven Bridges platform.

"The Seven Bridges platform makes it much easier for researchers to access, analyze, and share massive biomedical data sets, providing an ideal collaborative environment for all types of genomic research projects," Spatial Transcriptomics CEO Florian Baumgartner said in a statement. "This investment will not only help us continue to refine and develop the Spatial Transcriptomics tool set, but also allow us to make our technology available to more researchers, so that they can layer intuitive visual analysis on top of other approaches they are using to investigate genetic data."

Financial and other details of the deal were not disclosed.

Spatial Transcriptomics offers products that combine histology and gene-expression analysis by sequencing cDNA libraries created from transcripts obtained from specific locations in a sample by array-based capture probes.

The firm has also developed software to present the gene expression data along with morphology in a visualization, to show which expression can be found near which histological features.

Seven Bridges said it will make the technology available on its platform later this year. It will be the newest addition and the first of this year; in November, Seven Bridges announced it had integrated SolveBio's genomic data analysis into its platform.